Corcept Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Analysis

Corcept Therapeutics, Inc. (CORT)

34.04 -1.65 (-4.62%) USD | NASDAQ | Mar 05, 16:00

34.00 -0.04 (-0.12%) Pre-Market: 07:59

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for CORT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Axsome Therapeutics, Inc.	Upgrade
United Therapeutics Corp.	--
Harrow, Inc.	Upgrade
Ultragenyx Pharmaceutical, Inc.	Upgrade
Amneal Pharmaceuticals, Inc.	Upgrade